HomeClinical TopicsFDA approves extract for house dust mite allergic rhinitis

FDA approves extract for house dust mite allergic rhinitis

On March 1, the U.S. Food and Drug Administration (FDA) approved Odactra, the first allergen extract to be administered sublingually to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in people 18 through 65 years of age. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content

For Nurse Practitioners

covid-19 virus illustration

Will Omicron Be More Contagious Than Delta?

If the first thing you heard about the omicron variant over the holiday weekend was that it is bad news, the second thing was...